Make it a Double: Immunotherapy Combinations for Advanced Melanoma – Curetoday.com
|
Make it a Double: Immunotherapy Combinations for Advanced Melanoma
Curetoday.com Make it a Double: Immunotherapy Combinations for Advanced Melanoma. Increasingly, immunotherapy drugs for advanced melanoma are being studied in combination. PUBLISHED: JULY 07, 2017. Be the first to discuss this article on CURE’s forum. >>. |
IFLScience |
Debate Rages Over Safety Of CRISPR Gene-Editing Technique
IFLScience In the last few years, CRISPR – the precise and easily available gene-editing technique – has gone from strength to strength. Right now, it’s more potential than practical, but its uses are almost countless. From removing genetic diseases from babies … |
|
Capricor yo-yos as J&J dumps stem cell partnership
FierceBiotech After three and a half years, Johnson & Johnson is ducking out of a partnership with Capricor Therapeutics focused on the use of stem cells to treat cardiovascular disease. The decision by J&J’s Janssen unit not to pursue a license comes as little … |
Hindustan Times |
Diabetes alert: Stem Cell Educator therapy is safe and effective for treatment
Hindustan Times New research has revealed that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy is believed to provide benefits because abnormalities in multiple types of immune cells contribute … Brothers Michael and Alex Wood share a stem cell bond at the Stadium StompThe Advertiser The Global Market for Induced Pluripotent Stem Cells (iPSCs) should reach $3.6 Billion in 2021, Increasing at a CAGR …Business Wire (press release) ‘Educated’ immune cells hold promise for fight against diabeteseHealth Magazine | Elets |
|
Colon Cancer-Driven Stem Cells Linked to High-Fat Diet
Genetic Engineering & Biotechnology News Their research is published today, in Stem Cell Reports, in a paper titled, “RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.” The Cleveland Clinic team’s review of published research … |